RxDoctor Payments Data

Tommie Seymore Joly, PA

Medical · New Braunfels, TXNPI 1194059030

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,961 of the $8,941 with a category attached, or 89.0%. It is spread thinly across 27 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,941in general payments, 2019–2025

Across 415 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AbbVie$1K
  • Regeneron Healthcare Solutions, Inc.$933
  • Galderma Laboratories, L.p.$738
  • E.r. Squibb & Sons, L.L.C.$586
  • Novartis$504
  • plus $3K from 21 others

What the payments were for

  • Food & beverage$7,96189%
  • Education$98011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,941 in reported general payments places this provider in the 90th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas →

Medicare billing

Part B allowed, 2024
$212,617
Medicare patients
720
Services billed
7,956

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ivermectin12$4,556
Clobetasol Propionate83$4,054
Metronidazole57$3,415
Doxycycline Hyclate70$2,658
Ketoconazole168$2,043
Fluorouracil20$1,632
Tretinoin16$1,336
Clindamycin Phosphate30$1,321
Fluocinonide18$657
Triamcinolone Acetonide116$606
Mometasone Furoate28$485
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip13$409
Ciclopirox13$377
Hydroxychloroquine Sulfate16$375
Spironolactone25$357

Paid to pharmacies, not to this prescriber.

Other medical in New Braunfels

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →